Charles Baltic
Président chez MEI PHARMA, INC.
Fortune : 17 221 $ au 30/04/2024
Postes actifs de Charles Baltic
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEI PHARMA, INC. | Independent Dir/Board Member | 20/10/2011 | - |
Président | 05/01/2023 | - | |
Directeur/Membre du Conseil | 20/10/2011 | 05/01/2023 | |
SIDIS, Inc. | Corporate Officer/Principal | 01/01/2019 | - |
Directeur/Membre du Conseil | 01/01/2013 | 01/01/2019 | |
Assayquant Technologies, Inc. | Président | - | - |
Historique de carrière de Charles Baltic
Anciens postes connus de Charles Baltic
Sociétés | Poste | Début | Fin |
---|---|---|---|
Amyndas Pharmaceuticals LLC
Amyndas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amyndas Pharmaceuticals LLC is an American clinical-stage biopharmaceutical company that focuses on developing advanced complement therapies to treat inflammatory disorders in areas of unmet medical need. The private company has a robust R & D complement program with a diversified pipeline of C3 complement inhibitors. The company's priority clinical programs focus on kidney transplantation, PNH, C3G, periodontitis, AMD, and cancer immunotherapy. The company's lead candidates are recognized by the scientific community as the best C3-based complement inhibitors currently in development. Charles V. Baltic has been the CEO of the company since 2021. | Directeur Général | 01/03/2021 | 01/10/2022 |
Sidis Corp
Sidis Corp Financial ConglomeratesFinance Sidis Corp provides investment services for market-leading life science companies. | Directeur des opérations | 01/01/2019 | 01/01/2021 |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Corporate Officer/Principal | 01/01/2009 | 01/01/2019 |
Washington Biotechnology & Biomedical Association | Directeur/Membre du Conseil | 01/01/2013 | 01/01/2018 |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Directeur/Membre du Conseil | 01/01/2007 | 01/01/2017 |
US Securities & Exchange Commission | Corporate Officer/Principal | 01/01/2013 | 01/01/2015 |
░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░ ░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Charles Baltic
Georgetown University | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 16 |
Opérationnelle
Corporate Officer/Principal | 6 |
Director/Board Member | 5 |
Chairman | 2 |
Sectorielle
Finance | 7 |
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Entreprise privées | 12 |
---|---|
Cowen & Co. (New York) | Finance |
Wachovia Securities LLC
Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Finance |
CRT Capital Group LLC
CRT Capital Group LLC Investment Banks/BrokersFinance Founded in 1989, CRT Capital Group LLC is an institutional securities research and brokerage firm located in Stamford, Connecticut. The firm focuses on high-yield and convertible debt, capital structure arbitrage, mergers and acquisitions, special situations and distressed securities. CRT trades senior and subordinated bonds, bank debt, trade claims, convertible bonds, equities, real estate loans, tax exempt securities and private placements. | Finance |
US Securities & Exchange Commission | Finance |
Washington Biotechnology & Biomedical Association | |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
MedVantage, Inc. | |
SIDIS, Inc. | |
Amyndas Pharmaceuticals LLC
Amyndas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Amyndas Pharmaceuticals LLC is an American clinical-stage biopharmaceutical company that focuses on developing advanced complement therapies to treat inflammatory disorders in areas of unmet medical need. The private company has a robust R & D complement program with a diversified pipeline of C3 complement inhibitors. The company's priority clinical programs focus on kidney transplantation, PNH, C3G, periodontitis, AMD, and cancer immunotherapy. The company's lead candidates are recognized by the scientific community as the best C3-based complement inhibitors currently in development. Charles V. Baltic has been the CEO of the company since 2021. | Health Technology |
Sidis Corp
Sidis Corp Financial ConglomeratesFinance Sidis Corp provides investment services for market-leading life science companies. | Finance |
Assayquant Technologies, Inc. |
- Bourse
- Insiders
- Charles Baltic
- Expérience